12:00 AM
 | 
Nov 18, 2013
 |  BC Week In Review  |  Company News  |  Other News

Foundation Medicine, Foundation for the National Institutes of Health (FNIH), Friends of Cancer Research (FOCR), SWOG cancer, genomics news

Foundation Medicine will use its genomic platform to screen patients for the Phase II/III Master Protocol trial, which is a biomarker-driven collaborative study evaluating multiple candidates to treat squamous cell...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >